The International Paralympic Committee (IPC) has announced that Iranian shot putter Ahmad Ostavarian has been suspended for four years for an Anti-Doping Rule violation.
Ostavarian returned an adverse analytical finding for two substances: Metandienone metabolites Epimetandienone and Epimetendiol, and Trenbolone metabolite Epitrenbolone in a urine sample provided on 25 February 2015 after he had competed in the shot put F37 event at the 7th FAZZA Athletics Championships in Dubai, UAE, which doubles as the IPC Athletics Grand Prix.
These substances are included on the World Anti-Doping Agency (WADA) 2015 Prohibited List under the category S1.1a Anabolic Androgenic Steroids (AAS) and are prohibited at all times, both in and out of competition.
As a result of his violation, Ostavarian will be ineligible from competition for four years from 10 April 2015, the date the athlete was notified and provisionally suspended, until 9 April 2019.
All Ostavarian’s results obtained from the date of the test and onwards will be disqualified including forfeiture of any medals, points, records and prizes.
The principle of strict liability applies to anti-doping matters. Therefore, each athlete is strictly liable for the substances found in his or her sample, and that an anti-doping rule violation occurs whenever a prohibited substance (or its metabolites or markers) is found in his or her bodily specimen, whether or not the athlete intentionally or unintentionally used a prohibited substance or was negligent or otherwise at fault.
As a signatory of the World Anti-Doping Code (WADC), the IPC remains committed to a doping free sporting environment at all levels. The IPC, together with the International Federations and the National Paralympic Committees, established the IPC Anti-Doping Code to prevent doping in sport for Paralympic athletes, in the spirit of fair play. The IPC Anti-Doping Code is in conformity with the general principles of the WADC.